Department of Neuroscience, University of Turin Medical School, Turin, Italy.
Clin Pharmacol Ther. 2011 Nov;90(5):651-61. doi: 10.1038/clpt.2011.206. Epub 2011 Oct 12.
In placebo-controlled trials, the placebo component of treatments is usually assessed by simulating a therapy through the administration of a dummy treatment (placebo) in order to eliminate the specific effects of the therapy. Recently, a radically different approach to the analysis of placebo responses has been implemented in which placebo responses are assessed without placebo groups. To do this, the placebo (psychological) component is eliminated by conducting hidden (unexpected) administrations of the active treatment. Compelling experimental evidence now shows that when the psychological component is eliminated through the administration of therapies unbeknownst to the patient, the effects of a variety of treatments are significantly reduced. Overall, the experimental data show that the action of different pharmacological agents can be modulated by cognitive and affective factors that can increase or decrease the effects of drugs. This experimental approach is thus a window into the complex interactions between psychology and pharmacodynamics.
在安慰剂对照试验中,治疗的安慰剂部分通常通过给予模拟治疗的虚假治疗(安慰剂)来评估,以消除治疗的特定效果。最近,一种截然不同的安慰剂反应分析方法已经实施,其中无需安慰剂组即可评估安慰剂反应。为此,通过对患者未知的主动治疗进行隐藏(意外)给药,可以消除安慰剂(心理)成分。现在有令人信服的实验证据表明,当通过患者未知的治疗来消除心理成分时,各种治疗的效果会显著降低。总的来说,实验数据表明,不同药物的作用可以通过认知和情感因素进行调节,这些因素可以增加或减少药物的效果。因此,这种实验方法为研究心理学和药效学之间的复杂相互作用提供了一个窗口。